Sign in

CIK 0001889109

  • Large accelerated filer

BELITE BIO, INC

Sign in to watch
Ticker
BLTE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
Other
Phone
+1 858-246-6240
Business address
12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
Former names
BELITE BIO, INC
  1. 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $159.56 ($159,556)
  2. 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $166.28 ($166,284)
  3. 4 Other acquisition Chief Executive Officer acquired 10,000 shares (other)
  4. 4 Derivatives Options or other derivatives
  5. 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $170.38 ($170,384)
  6. 4 Other acquisition Chief Financial Officer acquired 10,000 shares (other)
  7. 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $166.00 ($166,000)
  8. 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $163.59 ($163,595)
  9. 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $161.63 ($161,630)
  10. 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $160.38 ($160,381)
  11. 4 Planned sale Chief Scientific Officer sold 1,000 shares at an average $168.30 ($168,298)
  12. 4 Planned sale Chief Executive Officer sold 9,200 shares at an average $181.45 ($1,669,339)
  13. 4 Planned sale Director sold 1,100 shares at $180.43 ($198,473)
  14. 4 Planned sale Chief Financial Officer sold 6,200 shares at an average $181.50 ($1,125,303)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 2 of 3 · 47 filings